{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T11:40:10Z","timestamp":1772192410827,"version":"3.50.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T00:00:00Z","timestamp":1757980800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T00:00:00Z","timestamp":1757980800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100002380","name":"Hanyang University","doi-asserted-by":"publisher","award":["HY-202400000003666"],"award-info":[{"award-number":["HY-202400000003666"]}],"id":[{"id":"10.13039\/501100002380","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008903","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["RS-2023-CC139201"],"award-info":[{"award-number":["RS-2023-CC139201"]}],"id":[{"id":"10.13039\/100008903","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s12282-025-01774-8","type":"journal-article","created":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T11:14:00Z","timestamp":1758021240000},"page":"80-87","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Prevalence of germline CHEK2 variants in East Asians and Koreans based on population genomic databases"],"prefix":"10.1007","volume":"33","author":[{"given":"Jong Eun","family":"Park","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taeheon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eun Hye","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mi-Ae","family":"Jang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongju","family":"Won","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Boyoung","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jung-Sook","family":"Ha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Do Hoon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyoung-Bo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chang-Seok","family":"Ki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0620-4058","authenticated-orcid":false,"given":"Sun-Young","family":"Kong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,9,16]]},"reference":[{"key":"1774_CR1","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1126\/science.282.5395.1893","volume":"282","author":"S Matsuoka","year":"1998","unstructured":"Matsuoka S, Huang M, Elledge SJ. Linkage of ATM to cell cycle regulation by the Chk2 protein kinase. Science. 1998;282:1893\u20137.","journal-title":"Science"},{"key":"1774_CR2","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1158\/1078-0432.CCR-10-1215","volume":"17","author":"A Stolz","year":"2011","unstructured":"Stolz A, Ertych N, Bastians H. Tumor suppressor CHK2: regulator of DNA damage response and mediator of chromosomal stability. Clin Cancer Res. 2011;17:401\u20135.","journal-title":"Clin Cancer Res"},{"key":"1774_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13092106","author":"P Apostolou","year":"2021","unstructured":"Apostolou P, Dellatola V, Papadimitriou C, Kalfakakou D, Fountzilas E, Faliakou E, et al. CHEK2 pathogenic variants in Greek breast cancer patients: evidence for strong associations with Estrogen Receptor positivity, overuse of risk-reducing procedures and population founder effects. Cancers (Basel). 2021. https:\/\/doi.org\/10.3390\/cancers13092106.","journal-title":"Cancers (Basel)"},{"key":"1774_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.gim.2023.100870","volume":"25","author":"H Hanson","year":"2023","unstructured":"Hanson H, Astiazaran-Symonds E, Amendola LM, Balma\u00f1a J, Foulkes WD, James P, et al. Management of individuals with germline pathogenic\/likely pathogenic variants in CHEK2: a clinical practice resource of the American College of Medical Genetics and Genomics (ACMG). Genet Med. 2023;25:100870.","journal-title":"Genet Med"},{"key":"1774_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13061378","author":"T Nguyen- Dumont","year":"2021","unstructured":"Nguyen-Dumont T, Dowty JG, Steen JA, Renault AL, Hammet F, Mahmoodi M, et al. Population-based estimates of the age-specific cumulative risk of breast cancer for pathogenic variants in CHEK2: findings from the Australian breast cancer family registry. Cancers (Basel). 2021. https:\/\/doi.org\/10.3390\/cancers13061378.","journal-title":"Cancers (Basel)"},{"key":"1774_CR6","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s10549-018-4673-6","volume":"169","author":"Z Fan","year":"2018","unstructured":"Fan Z, Ouyang T, Li J, Wang T, Fan Z, Fan T, et al. Identification and analysis of CHEK2 germline mutations in Chinese BRCA1\/2-negative breast cancer patients. Breast Cancer Res Treat. 2018;169:59\u201367.","journal-title":"Breast Cancer Res Treat"},{"key":"1774_CR7","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1002\/cam4.1376","volume":"7","author":"J Hauke","year":"2018","unstructured":"Hauke J, Horvath J, Gro\u00df E, Gehrig A, Honisch E, Hackmann K, et al. Gene panel testing of 5589 BRCA1\/2-negative index patients with breast cancer in a routine diagnostic setting: results of the German Consortium for Hereditary Breast and Ovarian Cancer. Cancer Med. 2018;7:1349\u201358.","journal-title":"Cancer Med"},{"key":"1774_CR8","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1001\/jamaoncol.2017.0424","volume":"3","author":"FJ Couch","year":"2017","unstructured":"Couch FJ, Shimelis H, Hu C, Hart SN, Polley EC, Na J, et al. Associations between cancer predisposition testing panel genes and breast cancer. JAMA Oncol. 2017;3:1190\u20136.","journal-title":"JAMA Oncol"},{"key":"1774_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1200\/PO.16.00066","volume":"1","author":"AW Kurian","year":"2017","unstructured":"Kurian AW, Hughes E, Handorf EA, Gutin A, Allen B, Hartman AR, et al. Breast and Ovarian cancer penetrance estimates derived from germline multiple-gene sequencing results in women. JCO Precis Oncol. 2017;1:1\u201312.","journal-title":"JCO Precis Oncol"},{"key":"1774_CR10","doi-asserted-by":"crossref","unstructured":"CHEK2*1100delC and susceptibility to breast cancer: a collaborative analysis involving 10,860 breast cancer cases and 9065 controls from 10 studies. Am J Hum Genet. 2004;74: 1175\u201382.","DOI":"10.1086\/421251"},{"key":"1774_CR11","doi-asserted-by":"publisher","first-page":"4083","DOI":"10.1038\/s41467-018-06581-8","volume":"9","author":"Y Momozawa","year":"2018","unstructured":"Momozawa Y, Iwasaki Y, Parsons MT, Kamatani Y, Takahashi A, Tamura C, et al. Germline pathogenic variants of 11 breast cancer genes in 7051 Japanese patients and 11,241 controls. Nat Commun. 2018;9:4083.","journal-title":"Nat Commun"},{"key":"1774_CR12","doi-asserted-by":"publisher","first-page":"3912","DOI":"10.1111\/cas.14600","volume":"111","author":"JS Ryu","year":"2020","unstructured":"Ryu JS, Lee HY, Cho EH, Yoon KA, Kim MK, Joo J, et al. Exon splicing analysis of intronic variants in multigene cancer panel testing for hereditary breast\/ovarian cancer. Cancer Sci. 2020;111:3912\u201325.","journal-title":"Cancer Sci"},{"key":"1774_CR13","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.4143\/crt.2021.978","volume":"54","author":"JS Park","year":"2022","unstructured":"Park JS, Shin S, Lee YJ, Lee ST, Nam EJ, Han JW, et al. Implication and influence of multigene panel testing with genetic counseling in Korean patients with BRCA1\/2 mutation-negative breast cancer. Cancer Res Treat. 2022;54:1099\u2013110.","journal-title":"Cancer Res Treat"},{"key":"1774_CR14","doi-asserted-by":"publisher","first-page":"148","DOI":"10.3343\/alm.2020.40.2.148","volume":"40","author":"J Yoo","year":"2020","unstructured":"Yoo J, Lee GD, Kim JH, Lee SN, Chae H, Han E, et al. Clinical validity of next-generation sequencing multi-gene panel testing for detecting pathogenic variants in patients with hereditary breast-ovarian cancer syndrome. Ann Lab Med. 2020;40:148\u201354.","journal-title":"Ann Lab Med"},{"key":"1774_CR15","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s10549-016-4034-2","volume":"161","author":"H Kim","year":"2017","unstructured":"Kim H, Cho DY, Choi DH, Oh M, Shin I, Park W, et al. Frequency of pathogenic germline mutation in CHEK2, PALB2, MRE11, and RAD50 in patients at high risk for hereditary breast cancer. Breast Cancer Res Treat. 2017;161:95\u2013102.","journal-title":"Breast Cancer Res Treat"},{"key":"1774_CR16","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.cancergen.2020.07.001","volume":"246\u2013247","author":"EG Sutcliffe","year":"2020","unstructured":"Sutcliffe EG, Stettner AR, Miller SA, Solomon SR, Marshall ML, Roberts ME, et al. Differences in cancer prevalence among CHEK2 carriers identified via multi-gene panel testing. Cancer Genet. 2020;246\u2013247:12\u20137.","journal-title":"Cancer Genet"},{"key":"1774_CR17","doi-asserted-by":"publisher","first-page":"3037","DOI":"10.1158\/1078-0432.CCR-23-0212","volume":"29","author":"L Stolarova","year":"2023","unstructured":"Stolarova L, Kleiblova P, Zemankova P, Stastna B, Janatova M, Soukupova J, et al. ENIGMA CHEK2gether project: a comprehensive study identifies functionally impaired CHEK2 germline missense variants associated with increased breast cancer risk. Clin Cancer Res. 2023;29:3037\u201350.","journal-title":"Clin Cancer Res"},{"key":"1774_CR18","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1001\/jamaoncol.2022.4071","volume":"8","author":"BL Bychkovsky","year":"2022","unstructured":"Bychkovsky BL, Agaoglu NB, Horton C, Zhou J, Yussuf A, Hemyari P, et al. Differences in cancer phenotypes among frequent CHEK2 variants and implications for clinical care-Checking CHEK2. JAMA Oncol. 2022;8:1598\u2013606.","journal-title":"JAMA Oncol"},{"key":"1774_CR19","unstructured":"National Comprehensive Cancer Network. Genetic\/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic (Version 3.2025) Available online: https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/genetics_bop.pdf (accessed on Apr 20, 2025)."},{"key":"1774_CR20","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1001\/jamaoncol.2021.6204","volume":"8","author":"KP Lowry","year":"2022","unstructured":"Lowry KP, Geuzinge HA, Stout NK, Alagoz O, Hampton J, Kerlikowske K, et al. Breast cancer screening strategies for women with ATM, CHEK2, and PALB2 pathogenic variants: a comparative modeling analysis. JAMA Oncol. 2022;8:587\u201396.","journal-title":"JAMA Oncol"},{"key":"1774_CR21","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1038\/s41586-020-2308-7","volume":"581","author":"KJ Karczewski","year":"2020","unstructured":"Karczewski KJ, Francioli LC, Tiao G, Cummings BB, Alf\u00f6ldi J, Wang Q, et al. The mutational constraint spectrum quantified from variation in 141,456 humans. Nature. 2020;581:434\u201343.","journal-title":"Nature"},{"key":"1774_CR22","doi-asserted-by":"publisher","first-page":"1862","DOI":"10.1038\/s12276-022-00871-4","volume":"54","author":"J Lee","year":"2022","unstructured":"Lee J, Lee J, Jeon S, Lee J, Jang I, Yang JO, et al. A database of 5305 healthy Korean individuals reveals genetic and clinical implications for an East Asian population. Exp Mol Med. 2022;54:1862\u201371.","journal-title":"Exp Mol Med"},{"key":"1774_CR23","doi-asserted-by":"publisher","DOI":"10.1093\/gigascience\/giae014","author":"S Jeon","year":"2024","unstructured":"Jeon S, Choi H, Jeon Y, Choi WH, Choi H, An K, et al. Korea4K: Whole genome sequences of 4,157 Koreans with 107 phenotypes derived from extensive health check-ups. Gigascience. 2024. https:\/\/doi.org\/10.1093\/gigascience\/giae014.","journal-title":"Gigascience"},{"key":"1774_CR24","doi-asserted-by":"crossref","unstructured":"Jung KS, Hong KW, Jo HY, Choi J, Ban HJ, Cho SB, et al. KRGDB: the large-scale variant database of 1722 Koreans based on whole genome sequencing. Database (Oxford). 2020;2020:baz146.","DOI":"10.1093\/database\/baaa030"},{"key":"1774_CR25","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17:405\u201324.","journal-title":"Genet Med"},{"key":"1774_CR26","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/j.ajhg.2016.08.016","volume":"99","author":"NM Ioannidis","year":"2016","unstructured":"Ioannidis NM, Rothstein JH, Pejaver V, Middha S, McDonnell SK, Baheti S, et al. REVEL: an ensemble method for predicting the pathogenicity of rare missense variants. Am J Hum Genet. 2016;99:877\u201385.","journal-title":"Am J Hum Genet"},{"key":"1774_CR27","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.cell.2018.12.015","volume":"176","author":"K Jaganathan","year":"2019","unstructured":"Jaganathan K, Kyriazopoulou Panagiotopoulou S, McRae JF, Darbandi SF, Knowles D, Li YI, et al. Predicting splicing from primary sequence with deep learning. Cell. 2019;176:535-48.e24.","journal-title":"Cell"},{"key":"1774_CR28","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1016\/j.ajhg.2022.10.013","volume":"109","author":"V Pejaver","year":"2022","unstructured":"Pejaver V, Byrne AB, Feng BJ, Pagel KA, Mooney SD, Karchin R, et al. Calibration of computational tools for missense variant pathogenicity classification and ClinGen recommendations for PP3\/BP4 criteria. Am J Hum Genet. 2022;109:2163\u201377.","journal-title":"Am J Hum Genet"},{"key":"1774_CR29","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1016\/j.ajhg.2023.06.002","volume":"110","author":"LC Walker","year":"2023","unstructured":"Walker LC, Hoya M, Wiggins GAR, Lindy A, Vincent LM, Parsons MT, et al. Using the ACMG\/AMP framework to capture evidence related to predicted and observed impact on splicing: recommendations from the ClinGen SVI splicing subgroup. Am J Hum Genet. 2023;110:1046\u201367.","journal-title":"Am J Hum Genet"},{"key":"1774_CR30","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/ng879","volume":"31","author":"H Meijers-Heijboer","year":"2002","unstructured":"Meijers-Heijboer H, van den Ouweland A, Klijn J, Wasielewski M, de Snoo A, Oldenburg R, et al. Low-penetrance susceptibility to breast cancer due to CHEK2(*)1100delC in noncarriers of BRCA1 or BRCA2 mutations. Nat Genet. 2002;31:55\u20139.","journal-title":"Nat Genet"},{"key":"1774_CR31","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16193318","author":"JE Park","year":"2024","unstructured":"Park JE, Kang MC, Lee T, Cho EH, Jang MA, Won D, et al. Prevalence estimation of the PALB2 germline variant in East Asians and Koreans through population database analysis. Cancers (Basel). 2024. https:\/\/doi.org\/10.3390\/cancers16193318.","journal-title":"Cancers (Basel)"},{"key":"1774_CR32","doi-asserted-by":"publisher","first-page":"917","DOI":"10.4143\/crt.2017.220","volume":"50","author":"KJ Eoh","year":"2018","unstructured":"Eoh KJ, Kim JE, Park HS, Lee ST, Park JS, Han JW, et al. Detection of germline mutations in patients with epithelial ovarian cancer using multi-gene panels: beyond BRCA1\/2. Cancer Res Treat. 2018;50:917\u201325.","journal-title":"Cancer Res Treat"},{"key":"1774_CR33","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1038\/s10038-018-0466-3","volume":"63","author":"P Apostolou","year":"2018","unstructured":"Apostolou P, Fostira F, Mollaki V, Delimitsou A, Vlassi M, Pentheroudakis G, et al. Characterization and prevalence of two novel CHEK2 large deletions in Greek breast cancer patients. J Hum Genet. 2018;63:877\u201386.","journal-title":"J Hum Genet"}],"container-title":["Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12282-025-01774-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12282-025-01774-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12282-025-01774-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,11]],"date-time":"2026-01-11T21:05:06Z","timestamp":1768165506000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12282-025-01774-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,16]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["1774"],"URL":"https:\/\/doi.org\/10.1007\/s12282-025-01774-8","relation":{},"ISSN":["1340-6868","1880-4233"],"issn-type":[{"value":"1340-6868","type":"print"},{"value":"1880-4233","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,16]]},"assertion":[{"value":"26 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"This study was approved by the Institutional Review Board of Hanyang University Guri Hospital (2021-06-29) and was conducted in accordance with the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Institutional review board statement"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent statement"}}]}}